Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Davis

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Pharmacy Practice|December 28, 2017
Ticagrelor for Neuroendovascular Procedures: A Case SeriesKyle Davis, Christopher Morrison
American Family Physician|May 14, 2016
Ivabradine (Corlanor) for Heart FailureKyle Davis, Eric Dietrich
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2016
Extended use of clopidogrel and aspirin after ischemic strokeKyle Davis, Eric Dietrich
Thrombosis Research|January 26, 2018
Argatroban dosing in obesityStephanie Elagizi, Kyle Davis
The Annals of Pharmacotherapy|June 25, 2014
A Statin a Day to Keep the Doctor Away? Comparing Aspirin and Statins for Primary Prevention of Cardiovascular DiseaseEric Dietrich, Kyle Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 18, 2012
Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patientMarta A Miyares, Kyle Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 25, 2012
Reversing the action of newer oral anticoagulants--author's replyMarta A Miyares, Kyle Davis
Vascular Health and Risk Management|September 15, 2012
Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapibMarta A Miyares, Kyle Davis
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2026
Milds Matter-Feasibility of Emicizumab Prophylaxis in Mild HemophiliaKyle Davis, Amy Shapiro, Sanjay Ahuja
Sports Medicine (Auckland, N.Z.)|April 27, 2013
Impact of clothing on exercise in the heatJon-Kyle Davis, Phillip A Bishop
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Pharmacy Practice|December 28, 2017
Ticagrelor for Neuroendovascular Procedures: A Case SeriesKyle Davis, Christopher Morrison
American Family Physician|May 14, 2016
Ivabradine (Corlanor) for Heart FailureKyle Davis, Eric Dietrich
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2016
Extended use of clopidogrel and aspirin after ischemic strokeKyle Davis, Eric Dietrich
Thrombosis Research|January 26, 2018
Argatroban dosing in obesityStephanie Elagizi, Kyle Davis
The Annals of Pharmacotherapy|June 25, 2014
A Statin a Day to Keep the Doctor Away? Comparing Aspirin and Statins for Primary Prevention of Cardiovascular DiseaseEric Dietrich, Kyle Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 18, 2012
Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patientMarta A Miyares, Kyle Davis
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 25, 2012
Reversing the action of newer oral anticoagulants--author's replyMarta A Miyares, Kyle Davis
Vascular Health and Risk Management|September 15, 2012
Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapibMarta A Miyares, Kyle Davis
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2026
Milds Matter-Feasibility of Emicizumab Prophylaxis in Mild HemophiliaKyle Davis, Amy Shapiro, Sanjay Ahuja
Sports Medicine (Auckland, N.Z.)|April 27, 2013
Impact of clothing on exercise in the heatJon-Kyle Davis, Phillip A Bishop
Pageof 5